MeTA - Uganda

Uganda is one of the seven countries taking part in the pilot phase of MeTA. The resources listed below relate specifically to Uganda.

We will add to this key list over time and would welcome suggestions or additions. Please send these to: sourceassistant@hi-uk.org

Selected resources

Books, reports, etc

Effective drug regulation : a multicountry study

RATANAWIJITRASIN, Sauwakon
WONDEMAGEGNEHU, Eshetu
2002

Expand view

This publication presents a synthesis of studies on drug regulation carried out in ten countries: Australia, Cuba, Cyprus, Estonia, Malaysia, the Netherlands, Tunisia, Uganda, Venezuela, and Zimbabwe in 1998-1999. It gives an overview of the development of drug regulation in these countries as well as the resources available and the strategies applied in drug regulation implementation at the time the studies were conducted. An analysis of the strengths and weaknesses in drug regulation in these countries is also provided

Medicine prices surveys and proposed interventions to improve sustainable access to affordable medicines in 6 sub-Saharan African countries|Etudes des prix des medicaments et interventions proposeees pur ameliorer durablement l'acces aux medicaments dan

WORLD HEALTH ORGANIZATION (WHO)
2006

Expand view

This document brings together the outcomes of six surveys into medicine prices - for Ghana, Kenya, Mali, Tanzania, Chad and Uganda - and one for the East African Community (Kenya, Uganda and Tanzania) . The reports for Mali and Chad are written in French and the others in English

Pain relieving drugs in 12 African PEPFAR countries : mapping current providers, identifying current challenges, and enabling expansion of pain control provision in the management of HIV/AIDS

HARDING, Richard
et al
January 2007

Expand view

This study aims to identify current opioid prescribing services and regulatory bodies within 12 African PEPFAR (Presidents Emergency Plan for AIDS Relief ) countries, and to examine the barriers to, and appraise the potential for, expansion in the number of opioid providers, for people with HIV and AIDS according to the World Health Organization pain ladder. It concludes that while there are common issues raised by services and International Narcotics Control Board competent authorities, it is clear that these key stakeholders have concerns regarding the potential roll-out of opioids

Report of a study on the civil society in Uganda : for the Royal Norwegian Embassy in Uganda

THUE, Nanna
MAKUBUYA, Apollo N.
NAKIRUNDA, Maureen
July 2002

Expand view

This study describes and analyses civil society in Uganda, including how civic actors relate to each other and to government and its policies at central and local level . The study also aims to identify important actual issues, actors and roles as well as the main challenges for civil society and their implications for Norway’s future relations with Uganda

The push for local production, costs and benefits - a case study of Uganda’s Quality Chemicals|Africa Fighting Malaria policy paper

TAYLOR, James
et al
September 2009

Expand view

This research report considers the challenges faced by a local pharmaceutical firm - Quality Chemicals - in Uganda, which was started up as a 'solution' to reducing the high cost of medicines and improving access to medicines. "...many burdens and barriers to access continue to seriously hinder the success of such enterprises. Indirect government subsidies to exporters selling into African markets, and pressure by donors and lobbyists on innovator producers to offer developing countries subsidised prices, actually undermine the competitiveness and viability of these nascent firms. Furthermore, the focus on drug pricing and local production can actually undermine the overall aim to increase access to medicines"

Uganda national drug policy

MINISTRY OF HEALTH, UGANDA
October 2002

Expand view

The Uganda national drug policy has been created to help ..."contribute to the attainment of a good standard of health by the population of Uganda, through ensuring the availability, accessibility and affordability of essential drugs of appropriate quality, safety and efficacy and by promoting their rational use"

Journal articles

The role of local manufacturers in improving access to essential medicines|Creating opportunities for the scale-up of local pharmaceutical production

MOHAMED, Nazeem
November 2009

Expand view

The local manufacturing of pharmaceuticals is a hotly contested issue in many countries. It runs to the heart of key concerns such as quality, availability, and price of medicines. Some of the arguments of the local manufacturers are set out in this article by one of the co-chairs of the Medicines Transparency Alliance Uganda Council and Chairman of the Uganda Pharmaceutical Manufacturer's Association (UPMA)